Israeli biotech firm files for $75 million Nasdaq IPO
Enzymotec, which makes additives, has 14 products and more in the pipeline.
Israeli biotech company Enzymotec has filed to float on Nasdaq under the trading symbol ENZY, intending to raise abut $75 million. The extent of its public float and share price at offering remain to be seen.
register with haaretz
Like us on Facebook and get articles directly in your news feed